Warman O’Brien, a specialist life sciences recruitment agency, has launched a partnership with Brain Tumour Research that will see employees fundraising to support the Charity’s work to find a cure for the disease.
Staff will take part in an array of activities to raise awareness and money. Their plans include participating in our national Walk of Hope event and Wear A Hat Day.
The organisation’s support comes after Director Charles Sealey was diagnosed with a brain tumour in 2025.
Charles underwent surgery to remove a subependymoma, a rare type of tumour, but experienced significant complications including developing hydrocephalus – a condition where pressure doesn’t align in the brain and cerebral spinal fluid is not processed normally. He required lumbar punctures which led to a shunt being put into his brain to control the pressure.
His recovery was set back by drug-induced hepatitis, severe weight loss and needing to learn how to walk again. Despite this ordeal, he has now returned to work and is dedicated to raising awareness of this deadly disease.
Charles said: “Working in life sciences recruitment has given me an awareness of the importance of medical and clinical development, but having to deal with a brain tumour diagnosis, surgery and recovery challenges, has given me a deeper understanding of the impacts of brain tumours.
“My experience has prompted Warman O’Brien to partner with Brain Tumour Research and raise funds for vital research. There’s an urgent need for more studies into the complexities of brain tumours and their impacts. To be able to directly give something back and give hope to patients and their loved ones means so much to us.”
One in three people in the UK knows someone affected by a brain tumour. This disease is indiscriminate; it can affect anyone at any age. What’s more, brain tumours continue to kill more children and adults under the age of 40 than any other cancer yet, to date, just 1% of the national spend on cancer research has been allocated to this devastating disease since records began in 2002.
Warman O'Brien was founded in 2017, focusing on connecting top talent with leading companies in the pharmaceutical and biotech industries across the UK, Europe, and North America.
We are delighted to welcome this partnership and are grateful to each member of staff for their support.
Related reading:
